Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

24.21

-0.19 (-0.78%)

At close: Oct 26, 2026, 4:00 PM EDT

24.36

+0.15 (0.62%)

Pre-market: Oct 27, 2026, 7:48 AM EDT

Viking Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-534.8	-359.64	-109.96	-85.9	-68.87	-54.99
Depreciation & Amortization	0.45	0.43	0.35	0.29	0.29	0.3
Other Amortization	0.01	0.06	0.09	0.09	0.06	0.02
Loss (Gain) From Sale of Investments	-6.02	-9.34	-17.38	-8.2	1.22	3.91
Stock-Based Compensation	37.39	40.82	29.71	16.75	8.67	6.1
Other Operating Activities	0.1	0.01	0.04	0.04	0.04	0.01
Change in Accounts Payable	63.52	43.44	2.3	-1.02	7.09	-2.54
Change in Other Net Operating Assets	20.9	5.54	7.06	4.57	3.1	-0.38
Operating Cash Flow	-418.44	-278.69	-87.79	-73.38	-48.4	-47.59
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Investment in Securities	399.26	341.39	-553.37	-179.09	54.75	37.96
Investing Cash Flow	399.26	341.39	-553.37	-179.09	54.75	37.96

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Issuance of Common Stock	111.25	76.44	654.57	278.5	12.51	7.63
Repurchase of Common Stock	-	-	-42.1	-7.12	-8.33	-0.71
Other Financing Activities	-	-	-	-	-0.02	-0.05
Financing Cash Flow	111.25	76.44	612.46	271.38	4.16	6.88

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	0.02	-0.01	-0.15	-0.03	-0.26	-
Net Cash Flow	92.08	139.13	-28.84	18.88	10.26	-2.75

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Levered Free Cash Flow	-230.79	-160.22	-55.58	-42.36	-25.22	-32.16
Unlevered Free Cash Flow	-230.8	-160.24	-55.61	-42.4	-25.24	-32.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Change in Working Capital	84.42	48.98	9.36	3.55	10.19	-2.93

SEC Filings: 10-K · 10-Q